| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/02/2004 | EP1372644A2 Use of substituted imidazo 1,2-a]-pyridine-3-yl-amide and imidazo 1,2-a]-pyridine-3-yl-amine compounds as medicaments |
| 01/02/2004 | EP1372632A1 Proliferative activator receptor (ppar) compounds |
| 01/02/2004 | EP1372627A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1372625A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors |
| 01/02/2004 | EP1372624A2 Tramadol-based medicament |
| 01/02/2004 | EP1372617A2 Enteric ketoacid salts and amino acids and their use for preparing medicines |
| 01/02/2004 | EP1372412A2 Composition improving age-related physiological deficits and increasing longevity |
| 01/02/2004 | EP1235830B1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS |
| 01/02/2004 | EP1036062B1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 01/01/2004 | US20040002613 Synthesis of benzonitriles from substituted benzoic acid |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002537 Multiple sclerosis; central nervous system disorders; side effect reduction |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002522 Antiinflammatory agents; analgesics |
| 01/01/2004 | US20040002521 Antiinflammatory agents; metalloprotease inhibitor; antiarthritic agents; antiallergens; viricides |
| 01/01/2004 | US20040002512 Alpha-substituted carboxylic acid derivatives |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002501 Modulate signal transduction; antitumor, anticancer agents, vision defects, antidiabetic agents, antiinflammatory agents |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002446 Central nervous system disorders; brain disorders; administering genetic engineered thrombomodulin |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040001867 Vectors for molecule delivery to CD11b expressing cells |
| 01/01/2004 | US20040001824 Cell proliferation inhibitors |
| 01/01/2004 | US20040001803 Effectors of innate immunity determination |
| 12/31/2003 | WO2004001424A1 Materials and methods for inductions of immune tolerance |
| 12/31/2003 | WO2004000887A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 12/31/2003 | WO2004000854A1 Sulfur-containing phospholipid derivatives |
| 12/31/2003 | WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 12/31/2003 | WO2004000843A1 NOVEL PURINE- OR PYRROLOL[2,3-d]PYRIMIDINE-2-CARBONITILES FOR TREATING DISEASES ASSOCIATED WITH CYSTEINE PROTEASE ACTIVITY |
| 12/31/2003 | WO2004000840A2 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 12/31/2003 | WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives |
| 12/31/2003 | WO2004000830A1 Novel compounds, their use and preparation |
| 12/31/2003 | WO2004000822A1 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 12/31/2003 | WO2004000819A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | WO2004000814A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | WO2004000807A1 Cannabinoid receptor agonists |
| 12/31/2003 | WO2004000806A1 Amides of cyclic amino acids used as pde 4 inhibitors |
| 12/31/2003 | WO2004000781A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 12/31/2003 | WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 12/31/2003 | WO2004000361A1 Metastable pharmaceutical compositions |
| 12/31/2003 | WO2004000357A1 Potentiating the antipyretic action of nonopioid analgesic |
| 12/31/2003 | WO2004000345A1 Preventives/remedies for bone and joint diseases |
| 12/31/2003 | WO2004000333A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/31/2003 | WO2004000324A1 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 12/31/2003 | WO2004000322A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000321A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 12/31/2003 | WO2004000314A1 Methods of using benzothiophenone derivatives to treat cancer or inflammation |
| 12/31/2003 | WO2004000311A2 Pharmaceutical composition comprising calcium channel blockers for the treatment of pain |
| 12/31/2003 | WO2004000308A1 Method of photodynamic diagnosis for vascular diseases |
| 12/31/2003 | WO2004000307A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 12/31/2003 | WO2004000294A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 12/31/2003 | WO2004000275A1 Transdermal aerosol compositions |
| 12/31/2003 | WO2004000226A2 Liposomes containing biologically active compounds |
| 12/31/2003 | WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 12/31/2003 | WO2004000116A1 Devices and methodologies useful in body aesthetics |
| 12/31/2003 | WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 12/31/2003 | WO2004000016A2 Antimicrobial compositions, products and methods employing same |
| 12/31/2003 | WO2003094911B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 12/31/2003 | WO2003080021A3 Formulation comprising buprenorphine |
| 12/31/2003 | WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/31/2003 | WO2003072704A3 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/31/2003 | WO2003068811A3 Cytotoxic t-cell epitopes from chlamydia |
| 12/31/2003 | WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 12/31/2003 | WO2003064638A3 Elongase gene and method for producing polyunsaturated fatty acids |
| 12/31/2003 | WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands |
| 12/31/2003 | WO2003059288A3 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 12/31/2003 | WO2003059269A3 Acridone inhibitors of impdh enzyme |
| 12/31/2003 | WO2003055916A3 Adiponectin fragments and conjugates |
| 12/31/2003 | WO2003055912A3 Secreted proteins |
| 12/31/2003 | WO2003020759A9 A caspase- 8 binding protein, its preparation and use |
| 12/31/2003 | WO2003010286A9 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/31/2003 | WO2002078747A9 Pregabalin lactose conjugates |
| 12/31/2003 | WO2002070562A3 Nuclear hormone receptor ligand binding domain |
| 12/31/2003 | WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/31/2003 | WO2002047708A3 Selective cox-2 inhibition from edible plant extracts |
| 12/31/2003 | WO2002047706A3 Selective cox-2 inhibition from plant extracts |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | WO2001006984A3 Small molecules useful in the treatment of inflammatory disease |
| 12/31/2003 | CN1464790A T cell receptor fusions and conjugates and methods of use thereof |
| 12/31/2003 | CN1463724A A pharmaceutical composition for treating lumbago and pain on legs |
| 12/31/2003 | CN1463722A A method for treating cancer and ache |
| 12/31/2003 | CN1463702A Analgetic pharmaceutical composition |
| 12/31/2003 | CN1463699A A composition for treating animal endometritis |
| 12/31/2003 | CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors |
| 12/31/2003 | CN1132814C 含有磺酰胺的吲哚化合物 Sulfonamide-containing indole compound |
| 12/31/2003 | CN1132616C Traditional Chinese medicine for treating arthralgia-syndrome |
| 12/31/2003 | CN1132612C Medicine for treating rheumatism and cold pain and its utilizing method |
| 12/31/2003 | CN1132609C Oral liquid for removing endogenous heat |
| 12/31/2003 | CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions |
| 12/31/2003 | CN1132577C Inhibition of nuclear transcription factor NF-'kappa' B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin |
| 12/31/2003 | CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |